Table 1.

Clinicopathological characteristics of all patients with non-inflammatory breast cancer (cT2) versus inflammatory breast cancer (cT4d)

	cT4d	cT2
Age, median (range), years	51.0 (38–67)	44.0 (39–67)
	n (%)	n (%)
Tumor subtype
Intraductal	15 (100)	12 (80.0)
Lobular	0 (0.0)	0 (0.0)
Other	0 (0.0)	0 (0.0)
Grade
1	0 (0.0)	0 (0.0)
2	3 (20.0)	1 (8.3)
3	3 (20.0)	3 (25.0)
Unknown	9 (60.0)	8 (66.7)
ER status
Positive	9 (60.0)	10 (83.3)
Negative	6 (40.0)	2 (16.7)
PR status
Positive	7 (46.7)	10 (83.3)
Negative	8 (53.3)	2 (16.7)
HER2 status
Positive	7 (46.7)	2 (16.7)
Negative	7 (46.7)	10 (83.3)
Unknown	1 (6.6)	0 (0.0)
Triple negative	4 (26.6)	2 (16.7)
Distant metastases	4 (26.6)	0 (0.0)

ER = Estrogen receptor; PR = progesterone receptor; HER2 = human epidermal growth factor receptor 2.